Wegovy has you covered across self-pay and commercial channels Novo Nordisk is committed to helping more patients achieve their weight-loss goals with broad access options Self-Pay Savings First two doses of 0.25 mg and 0.5 mg $199 per month* Then $349 per month 1 mg, 1.7 mg, and 2.4 mg doses $349 per month* 7.2 mg dose $399 per month* Commercial Insurance Savings All doses Patients pay as little as With the Wegovy savings offer Tell patients to text SAVE to 83757 , or patients can visit WegovySavings.com to view and sign up for savings offers *Patients new to the Wegovy Savings offer and NovoCare Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg
It has been shown to lead to better blood sugar control, improved hemoglobin levels, and greater weight loss in people with type 2 diabetes, compared with drugs that target GLP-1 alone
They can help pinpoint the cause and decide if any changes to your medication are necessary
Darryl Leong, MBBs,MPH,PhD,FRACP,FESC Principal Investigator Population Health Research Institute and McMaster University Jehonathan Pinthus, MD,FRCS(C),PhD Principal Investigator Juravinski Cancer Centre Are You a Good Fit for This Trial
Remember that erectile dysfunction often signals underlying health issues, so use it as motivation to address overall wellness
As a peptide-based drug, these enzymes in the body break down the peptide into amino acids that slow gastric emptying of food from the stomach to the intestinal tract to naturally reduce food consumption